Xiaomeng Wan
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoparticle-Based Drug Delivery 7
- Oncology 5
- Cancer Treatment and Pharmacology 3
- Co-authors
- Alexander V. Kabanov (7 shared papers)Rainer Jordan (6 shared papers)Herdis Bludau (6 shared papers)Marina Sokolsky‐Papkov (6 shared papers)Andrew Z. Wang (3 shared papers)Yuanzeng Min (2 shared papers)Robert Luxenhofer (4 shared papers)Anita Schulz (4 shared papers)
- Journals
- Nanomedicine Nanotechnology Biology and Medicine (2 papers)Biomaterials (2 papers)Chinese Journal of Natural Medicines (2 papers)ACS Nano (1 paper)Journal of Functional Foods (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xiaomeng Wan
13 papers receiving 738 citations
Peers
Comparison fields: 5 of 89
- Biomaterials 394
- Pharmaceutical Science 75
- Molecular Medicine 56
- Polymers and Plastics 117
- Organic Chemistry 185
Countries citing papers authored by Xiaomeng Wan
This map shows the geographic impact of Xiaomeng Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Wan more than expected).
Fields of papers citing papers by Xiaomeng Wan
This network shows the impact of papers produced by Xiaomeng Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Wan. The network helps show where Xiaomeng Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaomeng Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 174 | |
| 2 | 2016 | 166 | |
| 3 | 2018 | 139 | |
| 4 | 2015 | 85 | |
| 5 | 2015 | 57 | |
| 6 | 2018 | 49 | |
| 7 | 2016 | 25 | |
| 8 | 2023 | 14 | |
| 9 | 2017 | 13 | |
| 10 | 2016 | 11 | |
| 11 | 2021 | 9 | |
| 12 | 2016 | 4 | |
| 13 | 2023 | 1 | |
| 14 | 2020 | 1 |
About Xiaomeng Wan
Xiaomeng Wan is a scholar working on Biomaterials, Oncology, Surgery, Physiology and Biochemistry, having authored 14 papers that have together received 748 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Cancer Treatment and Pharmacology (3 papers), Lipid metabolism and biosynthesis (2 papers), Cholesterol and Lipid Metabolism (2 papers), Lanthanide and Transition Metal Complexes (2 papers), Digital Media and Visual Art (1 paper), Asian Culture and Media Studies (1 paper) and Innovation Policy and R&D (1 paper). The work is most often cited by research in Biomaterials (394 citations), Pharmaceutical Science (75 citations), Molecular Medicine (56 citations), Polymers and Plastics (117 citations) and Organic Chemistry (185 citations). Xiaomeng Wan has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Alexander V. Kabanov, Rainer Jordan, Herdis Bludau, Marina Sokolsky‐Papkov, Andrew Z. Wang, Yuanzeng Min, Robert Luxenhofer, Anita Schulz, Charles M. Perou and Daria Y. Alakhova. Their work appears in journals such as Nanomedicine Nanotechnology Biology and Medicine, Biomaterials, Chinese Journal of Natural Medicines, ACS Nano and Journal of Functional Foods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.